3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
18
Breast Neoplasms
16
Lung Neoplasms
10
Carcinoma, Non-Small-Cell Lung
6
Prostatic Neoplasms
5
Melanoma
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Skin Neoplasms
3
Myeloproliferative Disorders
3
Leukemia, Myeloid, Acute
3
Kidney Neoplasms
3
Head and Neck Neoplasms
3
Carcinoma, Hepatocellular
3
Recurrence
2
Neoplasm, Residual
2
Neoplasm Metastasis
2
Myelodysplastic Syndromes
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lung Diseases
2
Glioma
2
Glioblastoma
2
Genetic Predisposition to Disease
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Interventions
pembrolizumab
4
enfortumab vedotin
3
Gemcitabine
3
Cisplatin
2
zidovudine 5'-monophosphate-mannose-albumin conjugate
1
testosterone 17 beta-cypionate
1
temsirolimus
1
galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20
1
dodecyl maltoside
1
Valproic Acid
1
Testosterone Propionate
1
Sunitinib
1
Standard of Care
1
Sirolimus
1
Ringer's acetate
1
Radiation Dose Hypofractionation
1
Psychiatric Nursing
1
Practice Guidelines as Topic
1
Physical Therapy Modalities
1
Mitomycin
1
Methyltestosterone
1
Immunoglobulin G
1
Fluorouracil
1
Etoposide
1
Doxycycline
1
Disulfides
1
Cyclophosphamide
1
Cetuximab
1
Carboplatin
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Urologic Neoplasms
×
Blood Specimen Collection
×
90 days
×
Clear all
No trials found.